Innovation / Projects

Polycystic Ovary – Spiomed

Problem or need Between 5 and 10% of women of childbearing age suffer a metabolic disorder known as polycystic ovary syndrome or PCOS. Depending on how the condition manifests, they suffer from obesity, infertility and the development of male body characteristics.

SPIOMET treatment for PCOS normalized post-treatment ovulation rates more frequently than oral contraceptives (OC).

Focusing the treatment of PCOS on the early reduction of hepato-visceral fat may prevent part of the subsequent oligoanovulatory subfertility

Sector Pharmaceutics

Development stage

  • Basic research
  • Development
  • Approval and launch
  • Clinical trial / Validation
  • Pre-industrialization
  • Marketing